Alzheimer's: New Treatments But No Prevention Strategy15 years, 4 months ago
Posted on Jan 24, 2005, 4 a.m.
By Bill Freeman
While we hear that the Johnson & Johnson Alzheimer's drug Reminyl is associated with higher death rates than placebo, a new "scientific breakthrough" is already in the pipeline. By removing plaques in the brains of mice, which in humans are normally associated with Alzheimer's disease, it seems that some of the nerve damage which is characteristic of the disease, may have been reverted as well.